Drug Industry Daily
July 31, 2012
| Vol.
11 No.
149
FDA Lifts Import Alert, Sends Closeout Letter to Dr. Reddy’s Mexico API Plant
Dr. Reddy’s can once again export products from its Morelos, Mexico, manufacturing facility to the U.S. thanks to an FDA closeout letter and the removal of an import alert that stemmed from an unfavorable agency inspection more than a year ago.
This article is viewable by subscribers only. To view this article, please select an option below.
|